V019-1629 Screening compound: 2-{2-[(2-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one

V019-1629 Screening compound: 2-{2-[(2-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one
V019-1629 Screening compound: 2-{2-[(2-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-1629
2-{2-[(2-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-1629

Molecular Formula

C28H28ClFN4O (C28 H28 ClFN4 O)

Compound Name

2-{2-[(2-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one

IUPAC name

2-{2-[(2-chlorophenyl)methyl]-56-dimethyl-1H-13-benzodiazol-1-yl}-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one

SMILES

Cc(c(C)c1)cc2c1nc(Cc(cccc1)c1Cl)n2CC(N(CC1)CCN1c(cccc1)c1F)=O

InChI

InChI=1S/C28H28ClFN4O/c1-19-15-24-26(16-20(19)2)34(27(31-24)17-21-7-3-4-8-22(21)29)18-28(35)33-13-11-32(12-14-33)25-10-6-5-9-23(25)30/h3-10,15-16H,11-14,17-18H2,1-2H3

InChI Key

REZZIGIKYJGQEL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19785812

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

491.01

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.271

Distribution Coefficient, logD

6.185

Water Solubility, LogSw

-6.01

Polar Surface Area

30.224

Acid Dissociation Constant (pKa)

18.43

Base Dissociation Constant (pKb)

6.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

V019-1629 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V019-1629 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-1629?
Check Price and Availability of V019-1629, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-1629 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-1629
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-1629
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-1629 available by request